Stern DM - Search Results

1

Schmidt AM, Yan SD, Stern DM. Schmidt AM, et al. Among authors: stern dm. Nat Med. 1995 Oct;1(10):1002-4. doi: 10.1038/nm1095-1002. Nat Med. 1995. PMID: 7489352 No abstract available.

2

Suppression of experimental autoimmune encephalomyelitis by selective blockade of encephalitogenic T-cell infiltration of the central nervous system.

Yan SS, Wu ZY, Zhang HP, Furtado G, Chen X, Yan SF, Schmidt AM, Brown C, Stern A, LaFaille J, Chess L, Stern DM, Jiang H. Yan SS, et al. Among authors: stern a, stern dm. Nat Med. 2003 Mar;9(3):287-93. doi: 10.1038/nm831. Epub 2003 Feb 24. Nat Med. 2003. PMID: 12598893

3

Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases.

Taguchi A, Blood DC, del Toro G, Canet A, Lee DC, Qu W, Tanji N, Lu Y, Lalla E, Fu C, Hofmann MA, Kislinger T, Ingram M, Lu A, Tanaka H, Hori O, Ogawa S, Stern DM, Schmidt AM. Taguchi A, et al. Among authors: stern dm. Nature. 2000 May 18;405(6784):354-60. doi: 10.1038/35012626. Nature. 2000. PMID: 10830965

4

The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses.

Schmidt AM, Yan SD, Yan SF, Stern DM. Schmidt AM, et al. Among authors: stern dm. J Clin Invest. 2001 Oct;108(7):949-55. doi: 10.1172/JCI14002. J Clin Invest. 2001. PMID: 11581294 Free PMC article. Review. No abstract available.

5

Cellular receptors for advanced glycation end products. Implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions.

Schmidt AM, Hori O, Brett J, Yan SD, Wautier JL, Stern D. Schmidt AM, et al. Arterioscler Thromb. 1994 Oct;14(10):1521-8. doi: 10.1161/01.atv.14.10.1521. Arterioscler Thromb. 1994. PMID: 7918300 Review.

6

RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease.

Yan SD, Chen X, Fu J, Chen M, Zhu H, Roher A, Slattery T, Zhao L, Nagashima M, Morser J, Migheli A, Nawroth P, Stern D, Schmidt AM. Yan SD, et al. Nature. 1996 Aug 22;382(6593):685-91. doi: 10.1038/382685a0. Nature. 1996. PMID: 8751438

7

What's the RAGE? The receptor for advanced glycation end products (RAGE) and the dark side of glucose.

Yan SD, Stern D, Schmidt AM. Yan SD, et al. Eur J Clin Invest. 1997 Mar;27(3):179-81. doi: 10.1046/j.1365-2362.1996.00072.x. Eur J Clin Invest. 1997. PMID: 9088851 Review. No abstract available.

8

Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts.

Park L, Raman KG, Lee KJ, Lu Y, Ferran LJ Jr, Chow WS, Stern D, Schmidt AM. Park L, et al. Nat Med. 1998 Sep;4(9):1025-31. doi: 10.1038/2012. Nat Med. 1998. PMID: 9734395

9

Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis.

Schmidt AM, Yan SD, Wautier JL, Stern D. Schmidt AM, et al. Circ Res. 1999 Mar 19;84(5):489-97. doi: 10.1161/01.res.84.5.489. Circ Res. 1999. PMID: 10082470 Review.

10

Receptor-dependent cell stress and amyloid accumulation in systemic amyloidosis.

Yan SD, Zhu H, Zhu A, Golabek A, Du H, Roher A, Yu J, Soto C, Schmidt AM, Stern D, Kindy M. Yan SD, et al. Nat Med. 2000 Jun;6(6):643-51. doi: 10.1038/76216. Nat Med. 2000. PMID: 10835680

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

270 results

Search Page